clodronic acid has been researched along with Hormone-Dependent Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimura, K; Nonomura, N; Okuyama, A; Takahara, S | 1 |
| Saad, F | 1 |
| Bankhead, C | 1 |
| Campagnari, JC; Hering, F; Rodrigues, P | 1 |
| Englund, G; Larsson, B; Larsson, L; Magnusson, P; Selin-Sjögren, L; Strang, P | 1 |
1 review(s) available for clodronic acid and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
[Therapy for hormone-refractory prostate cancer].
Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Cyclophosphamide; Dexamethasone; Docetaxel; Estramustine; Humans; Male; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Strontium Radioisotopes; Taxoids; Tegafur; Treatment Outcome | 2002 |
1 trial(s) available for clodronic acid and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Clodronic Acid; Collagen; Collagen Type I; Double-Blind Method; Humans; Isoenzymes; Male; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Osteocalcin; Pain, Intractable; Peptides; Prostate-Specific Antigen; Prostatic Neoplasms | 1998 |
3 other study(ies) available for clodronic acid and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Bisphosphonates in prostate cancer: where are we and where should we go?
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Male; Neoplasms, Hormone-Dependent; Osteoporosis; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zoledronic Acid | 2003 |
Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Clodronic Acid; Diphosphonates; Disease-Free Survival; Humans; Imidazoles; Male; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Hormone-Dependent; Osteoporosis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Zoledronic Acid | 2003 |
Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Bone Neoplasms; Clodronic Acid; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prospective Studies; Prostatic Neoplasms; Time Factors | 2004 |